"Sylvester Comprehensive Cancer Center opened in 1992 to provide comprehensive cancer services to the South Florida community. Together with the 40-bed inpatient hospital, UMHC – University of Miami Hospital & Clinics, Sylvester serves as the cancer diagnosis, treatment, and research hub for UHealth – University of Miami Health System. Sylvester in Miami offers outpatient clinics, a 40-bed inpatient unit, a comprehensive treatment unit, a radiation oncology suite, the Mohs surgery center/dermatology clinic, the Rosenfield GI Center, a stem cell transplant clinic, a cardiology lab and clinic, a radiology/imaging suite, an interventional radiology clinic, the Spine Institute clinics, on-site laboratory and pharmacy."

During the past decade, University of Miami Miller School of Medicine-Sylvester Cancer Center conducted 365 clinical trials. In the 10-year time frame, 365 clinical trials started and 229 clinical trials were completed, i.e. on average, 62.7% percent of trials that started reached the finish line to date. In the past 5 years, 156 clinical trials started and 123 clinical trials were completed. i.e. 78.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miami Miller School of Medicine-Sylvester Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 139 trials, followed by "Children's Oncology Group" with 108 trials sponsored, "Radiation Therapy Oncology Group" with 62 trials sponsored, "University of Miami" with 48 trials sponsored and "SWOG Cancer Research Network" with 48 trials sponsored. Other sponsors include 370 different institutions and companies that sponsored additional 191 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami Miller School of Medicine-Sylvester Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 303 trials as a collaborator, "NRG Oncology" with 42 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator and "North Central Cancer Treatment Group" with 11 trials as a collaborator. Other collaborators include 206 different institutions and companies that were collaborators in the rest 114 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami Miller School of Medicine-Sylvester Cancer Center" are "Breast Cancer" (39 trials), "Head and Neck Cancer" (30 trials), "Lymphoma" (30 trials), "Sarcoma" (21 trials) and "Leukemia" (20 trials). Many other conditions were trialed in "University of Miami Miller School of Medicine-Sylvester Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Miami Miller School of Medicine-Sylvester Cancer Center" are "Drug" (586 trials), "Biological" (232 trials), "Other" (215 trials), "Radiation" (184 trials) and "Procedure" (171 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (111 trials), "radiation therapy" (62 trials), "Quality-of-Life Assessment" (59 trials), "Cyclophosphamide" (56 trials) and "Biospecimen Collection" (45 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami Miller School of Medicine-Sylvester Cancer Center" are 652 trials for "All" genders, 77 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "University of Miami Miller School of Medicine-Sylvester Cancer Center". undefined are not yet recruiting, 150 are recruiting, 195 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 323 completed trials in University of Miami Miller School of Medicine-Sylvester Cancer Center, 7 suspended trials, and 56 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami Miller School of Medicine-Sylvester Cancer Center, 147 "Phase 1" clinical trials were conducted, 345 "Phase 2" clinical trials and 279 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 34 trials that are defined as “Not Applicable".